Specific and effective targeting cancer immunotherapy with a combination of three bispecific antibodies.

Source:http://linkedlifedata.com/resource/pubmed/id/11852114

Immunol. Lett. 2002 Apr 22 81 2 99-106

Download in:

View as

General Info

PMID
11852114